{
  "image_filename": "figure_p4_mrg_det_3_001.png",
  "image_path": "Arunachalam_et_al.__2021_/extracted/figures/figure_p4_mrg_det_3_001.png",
  "image_type": "Figure",
  "page_number": 4,
  "block_id": "mrg_det_3_001",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "Schematic diagram comparing structural features of influenza hemagglutinin (HA) extracted from virus (HA1 and HA2 heterodimer with complex sialylated N-linked glycans and cleaved fusion peptide) versus recombinant HA (HA0 precursor expressed in insect cells with paucimannose glycans and uncleaved fusion peptide). The figure illustrates differences in glycosylation and cleavage between native viral HA and recombinant HA produced in insect cells but does not present any data on antigenic matching to WHO- or FDA-selected flu strains, and thus does not support the claim. Note: None",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Schematic diagram comparing structural features of influenza hemagglutinin (HA) extracted from virus (HA1 and HA2 heterodimer with complex sialylated N-linked glycans and cleaved fusion peptide) versus recombinant HA (HA0 precursor expressed in insect cells with paucimannose glycans and uncleaved fusion peptide).",
    "evidence_found": null,
    "reasoning": "The figure illustrates differences in glycosylation and cleavage between native viral HA and recombinant HA produced in insect cells but does not present any data on antigenic matching to WHO- or FDA-selected flu strains, and thus does not support the claim.",
    "confidence_notes": "None"
  }
}